The European treatment of severe atopic eczema in children taskforce (TREAT) survey

British Journal of Dermatology

Volumn 169, Issue 4, 2013, Pages 901-909

  Proudfoot, L E ^a   Powell, A M ^a   Ayis, S ^a   Barbarot, S ^b   Baselga Torres, E ^c   Deleuran, M ^d   Folster Holst R ^e   Gelmetti, C ^f   Hernandez Martin A ^g   Middelkamp Hup, M A ^h   Oranje, A P ⁱ   Logan, K ^j   Perkins, M ^j   Patrizi, A ^k   Rovatti, G ^f   Schofield, O ^l   Spuls, P ^h   Svensson, A ^m   Vestergaard, C ^d   Wahlgren, C F ⁿ   Schmitt, J ^o   Flohr, C ^a   more..

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b HÔTEL DIEU   (France)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^f UNIVERSITY OF MILAN   (Italy)

^g HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^h ACADEMIC MEDICAL CENTER   (Netherlands)

ⁱ Maasstad Hospital Rotterdam   (Netherlands)

^j KING'S COLLEGE LONDON   (United Kingdom)

^k UNIVERSITY OF BOLOGNA   (Italy)

^l ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^m LUND UNIVERSITY   (Sweden)

ⁿ KAROLINSKA INSTITUTE   (Sweden)

^o DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; CYCLOSPORIN A; EFALIZUMAB; MACROLIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OMALIZUMAB; PENICILLIN DERIVATIVE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ATOPIC DERMATITIS; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; FEMALE; HEALTH SURVEY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; MALE; MEDICAL PRACTICE; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SKIN INFECTION;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; DERMATOLOGY; EUROPE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; STAPHYLOCOCCAL SKIN INFECTIONS; YOUNG ADULT;

EID: 84885657069     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12505     Document Type: Review

References (35)

1. Leung DY, Bieber T,. Atopic dermatitis. Lancet 2003; 361: 151-60.
2. McAleer MA, Flohr C, Irvine AD,. Management of difficult and severe eczema in childhood. BMJ 2012; 345: e4770.
3. Hanifin JM, Thurston M, Omoto M, et al,. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol 2001; 10: 11-18.
4. Stalder JF, Taieb A,. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993; 186: 23-31.
5. Vourc'h-Jourdain M, Barbarot S, Taïeb A, et al,. Patient-oriented SCORAD: a self-assessment score in atopic dermatitis. A preliminary feasibility study. Dermatology 2009; 218: 246-51.
6. Emerson RM, Charman CR, Williams HC,. The Nottingham Eczema Severity Score: preliminary refinement of the Rajka and Langeland grading. Br J Dermatol 2000; 142: 288-97.
7. Berth-Jones J,. Six area, six sign atopic dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol 1996; 135 (Suppl. 48): 25-30.
8. Charman CR, Venn AJ, Williams HC,. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. Arch Dermatol 2004; 140: 1513-19.
9. Holme SA, Man I, Sharpe JL, et al,. The Children's Dermatology Life Quality Index: validation of the cartoon version. Br J Dermatol 2003; 148: 285-90.
10. Lewis-Jones MS, Finlay AY, Dykes PJ,. The infants' dermatitis quality of life index. Br J Dermatol 2001; 144: 104-10.
11. Lawson V, Lewis-Jones MS, Finlay AY, et al,. The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br J Dermatol 1998; 138: 107-13.
12. Chren MM, Lasek RJ, Quinn LM, et al,. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996; 107: 707-13.
13. Bemanian MH, Movahedi M, Farhoudi A, et al,. High doses intravenous immunoglobulin versus oral cyclosporine in the treatment of severe atopic dermatitis. Iran J Allergy Asthma Immunol 2005; 4: 139-43.
14. Harper JI, Ahmed I, Barclay G, et al,. Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol 2000; 142: 52-8.
15. Heddle RJ, Soothill JF, Bulpitt CJ, Atherton DJ,. Combined oral and nasal beclomethasone diproprionate in children with atopic eczema: a randomized controlled trial. Br Med J (Clin Res Ed) 1984; 289: 651-4.
16. Jee SJ, Kim JH, Baek HS, et al,. Long-term efficacy of intravenous immunoglobulin therapy for moderate to severe childhood atopic dermatitis. Allergy Asthma Immunol Res 2011; 3: 89-95.
17. La Rosaa M, Musarra I, Ranno C, et al,. A randomized, double-blind, placebo-controlled, crossover trial of systemic flunisolide in the treatment of children with severe atopic dermatitis. Curr Ther Res 1995; 56: 720-6.
18. Pei AY, Chan HH, Leung TF,. Montelukast in the treatment of children with moderate-to-severe atopic dermatitis: a pilot study. Pediatr Allergy Immunol 2001; 12: 154-8.
19. Berth-Jones J, Finlay AY, Zaki I, et al,. Cyclosporine in severe childhood atopic dermatitis: a multicenter study. J Am Acad Dermatol 1996; 34: 1016-21.
20. Ricci G, Dondi A, Patrizi A, Masi M,. Systemic therapy of atopic dermatitis in children. Drugs 2009; 69: 297-306.
21. Wei L, Liu B, Tuo J, et al,. Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. Cell Rep 2012; 2: 1151-8.
22. Pedreira CC, King E, Jones G, et al,. Oral cyclosporin plus topical corticosteroid therapy diminishes bone mass in children with eczema. Pediatr Dermatol 2007; 24: 613-20.
23. Krakowski AC, Eichenfield LF, Dohil MA,. Management of atopic dermatitis in the pediatric population. Pediatrics 2008; 122: 812-24.
24. Haeck IM, Knol MJ, Ten Berge O, et al,. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial. J Am Acad Dermatol 2011; 64: 1074-84.
25. Bunikowski R, Staab D, Kussebi F, et al,. Low-dose cyclosporin A microemulsion in children with severe atopic dermatitis: clinical and immunological effects. Pediatr Allergy Immunol 2001; 12: 216-23.
26. El-Khalawany MA, Hassan H, Shaaban D, et al,. Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt. Eur J Pediatr 2013; 172: 351-6.
27. Berth-Jones J, Takwale A, Tan E, et al,. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial. Br J Dermatol 2002; 147: 324-30.
28. Meggitt SJ, Gray JC, Reynolds NJ,. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomized controlled trial. Lancet 2006; 367: 839-46.
29. Hon KL, Ching GK, Leung TF, et al,. Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults. J Dermatolog Treat 2009; 20: 141-5.
30. Caufield M, Tom WL,. Oral azathioprine for recalcitrant pediatric atopic dermatitis: clinical response and thiopurine monitoring. J Am Acad Dermatol 2013; 68: 29-35.
31. Schram ME, Roekevisch E, Leeflang MM, et al,. A randomized trial of methotrexate versus azathioprine for severe atopic eczema. J Allergy Clin Immunol 2011; 128: 353-9.
32. Borchard KL, Orchard D,. Systemic therapy of paediatric atopic dermatitis: an update. Australas J Dermatol 2008; 49: 123-34, quiz 135-6.
33. Heller M, Shin HT, Orlow SJ, Schaffer JV,. Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients. Br J Dermatol 2007; 157: 127-32.
34. Birnie AJ, Bath-Hextall FJ, Ravenscroft JC, Williams HC,. Interventions to reduce Staphylococcus aureus in the management of atopic eczema. Cochrane Database Syst Rev 2008; 3: CD003871.
35. Staab D, Diepgen TL, Fartasch M, et al,. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ 2006; 332: 933-8.